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Introduction 
Modern vaccines are one of the most effective approaches 
to reduce mortality and to control infectious disease in the 
human population [1][2]. However, a number of problems 
remain unresolved in the field of vaccine use (efficacy). 
When developing vaccines an essential part of the 
research is not only to confirm their high immunogenicity 
and the presence of protective properties against infection, 
the pathogens, but also is necessary to determine the 
absence of reactogenicity and allergenicity. Both 
reactogenicity and allergenicity are associated with the 
presence of allergenic antigens and haptens in the vaccine 
[3]. 
These abnormal antigens are formed during the 
chemical inactivation of the microorganisms which 
produce vaccine antigens by inactivators such as formalin 
and propiolactone, as well as mercury preparations such as 
merthiolate. As a result of a chemical reaction between 
formalin and amino groups of proteins, Schiff bases are 
formed, which are then oxidized to formylated amino acid 
residues [4,5]. At the same time, the antigenicity of the 
initial proteins changes significantly, and the vaccinated 
organism synthesizes antibodies not to the original antigen, 
but to a formylated one [6]. 
In fact, usually the initial immunogenicity of 
microbial proteins under the action of formalin decreases 
twofold or more.   Moreover, abnormal formylated 
proteins, lipoproteins, often act as allergens [7]. Reducing 
the allergenicity and reactogenicity of antigens is possible, 
if microorganism- producent vaccine antigens is 
inactivated by methods that exclude the formation of 
covalent bonds between proteins and inactivators. 
Accordingly, inactivation of MSVA occurs 
without the formation of new abnormal antigens / 
allergens. One of the directions in the development of non-
reactogenic and non-allergenic vaccines is the replacement 
of formalin and propiolactone with non-covalent 
inactivators. This is one of the most promising methods for 
non-covalent inactivation of MSVA, because is the use of 
photodynamic inactivation using riboflavin derivatives [8]. 
Past research has established that riboflavin 
derivatives have the ability to selectively accumulate in the 
region of flavin aptamers of DNA / RNA in the cell, 
without violating the vital functions of the cell and the 
functioning of proteins [9,10].  
In fact, after above method approach, an MSVA 
inactivated remains with intact proteins, but with destroyed 
and lysed DNA and RNA [11]. After irradiation of 
riboflavin a harmless lumiflavin is formed. Lumiflavin is 
also a metabolite of human tissues and does not require 
cleaning the vaccine from it (as it used for formalin and 
merthiolate) [12]. 
The immunogenicity of proteins - vaccine 
antigens does not decrease, and allergenicity and 
reactogenicity does not increase, because the structure of 
the proteins as a whole remains unchanged. The method of 
riboflavin inactivation of infectious agents widely used in 
hematology in blood products for transfusion.  This method 
used for disinfection donated blood on Mirasol devices 
[12].   
 It was proven the safety and high inactivating 
activity against microorganisms of the photoinactivation 
system. Unfortunately, there are very few publications in 
regards of the effect of riboflavin inactivation on 
immunogenicity, allergenicity, reactogenicity and 
protective properties of vaccines [13].  One of the 
disadvantages of riboflavin inactivation is low solubility of 
riboflavin and its low permeability through the microbial 
membrane.  For a number of riboflavin derivatives, an 
increase in antimicrobial activity under the same 
conditions by 6 log CFU was previously shown [14]. 
Based on TRIZ (the Theory of Inventive Problem 
Solving) and the experience of our predecessors, our 
company came up with a solution to the problem outlined 
above, by synthesizing a dynamic self-organizing 
riboflavin derivative, the activity of which was higher with 
respect to the conversion of toxin to toxoid. We applied 
TRIZ-a new philosophy of thinking which is a problem-
solving, analysis and forecasting tool derived from the 
study of patterns of invention evolution and getting 
generalizable patterns in the nature of inventive solutions. 
It was discovered several trends (so called Laws of 
Systems Evolution) that help researchers predict the most 
likely developments that can be made to a given product. 
TRIZ has been successfully applied in in huge varieties of 
different fields all over the world, however, for the design 
of drugs of new generations at all stages of development. 
TRIZ could significantly decrease expenses, but has not 
been used systematically. The application of the principles 
of TRIZ in pharmaceutical industry and pharmacology 
opens up broad prospects in the creation of new classes of 
drugs. Therefore, pharmaceutical industry and 
pharmacology are huge areas to explore by TRIZ [15]. 
We utilized Urease, adynamic riboflavin 
derivative (RD) that has greater solubility (2% or more) 
and is more active in relation to urease photoactivation 
upon irradiation of the solution in the visible spectrum at 
450 nm within 3 minutes. We have done extensive 
pioneering work in this area established the safety and high 
inactivating activity against microorganisms of the 
photoinactivation system.  
Our company came up with solution by 
synthesizing a dynamic self-organizing riboflavin 
derivative, the activity of which was an order of magnitude 
higher with respect to the conversion of toxin to toxoid, 
using urease as an example [16]. This dynamic riboflavin 
derivative (RD) had greater solubility (2% or more) and 
was more active in relation to urease photoactivation upon 
irradiation of the solution in the visible spectrum at 450 nm 
within 3 minutes. 
The aim of this study was to determine of 
dependence of the intensity of exposure time by visible 
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radiation on the bacterial and the number of bacteria.   This 
dependence is important for the development of a universal 
method of inactivation in the development of low-
allergenic and non-reactogenic vaccines. Also, this 
research project includes study of the protective properties 
of the Pseudomonas corpuscular vaccine, which obtained 
through photodynamic inactivation using RD (riboflavin 
derivative) and visible blue light exposure at 450 nm (BL). 
We have chosen consciously the use of the visible 
region of the spectrum. Riboflavin and its derivatives are 
characterized by two peaks of light absorption - ultraviolet 
in the region of 250 nm and in the visible region (blue light) 
at 450 nm [17].   Light of the visible spectrum is not 
absorbed by water, unlike ultraviolet light [18]. Light of the 
visible spectrum penetrates not only deep into the nutrient 
medium, but also through the cell membranes of bacteria 
[19]. In fact, for light with a wavelength of 450 nm, there 
are no obstacles to the selective riboflavin photo nuclease 
activity inside flavin aptamers which may last up to 2-3 
minutes. 
Existing and known methods of photoinactivation 
of bacteria require a longer period of processing the 
solution with ultraviolet light with obligatory mixing of the 
solution (at least 20 minutes) and more intense radiation of 
ultraviolet lamps [20]. This requirement due to the low 
permeability of aqueous solutions for ultraviolet radiation 
with wavelengths of 220-300 nm. 
 It was not possible to completely suppress the growth of 
bacteria, and an increase light exposure is undesirable due 
to heating effect of the solution. Same time an increase in 
the concentration of riboflavin (R) is impossible due to its 
low solubility in water. Greater efficiency of inactivation 
was observed with a longer exposure (up to 40 minutes) or 
with a higher concentration of riboflavin and only when 
ultraviolet radiation was used [21]. 
The use of ultraviolet radiation is undesirable, 
especially for a long time, due to the risk of influencing 
antigenicity and immunogenicity. It happens due to the 
decarboxylation of external residues of protein amino acids 
as a result of direct exposure to ultraviolet radiation [20]. 
Unlike ultraviolet light, visible light penetrates deep into 
bacterial cells and the turbidity of the solution does not 
interfere with it. However, our results show quite a strong 
response and would be a very strong step forward in 
improving vaccine efficacy. 
The aim of our studies was to determine the 
photoinactivation efficiency of RD of the most common 
pathogenic bacteria: P. aeruginosa and E. coli at 450 nm. 
Goal was also to determine different concentrations of 
bacteria in solution, and also to confirm the presence of 
protective properties in the resulting antigens with respect 
to the development of P. aeruginosa and E. coli sepsis 
respectively in mice models. As control model, the same 
corpuscular antigens were used, but inactivated with 
formalin according to the standard inactivation protocols. 
 
Materials and Methods 
The methodology of our research was based on 
experiments with riboflavin and ultraviolet irradiation of 
bacterial suspensions described in [20]. 
To test our novel process, we utilized an animal 
vaccine method of testing. 
In the experiment, white outbred mice were used, which 
were kept on a vivarium diet under standard conditions. 
The animals were cared for according to the 
international guidelines GOST 33647-2015 (Principles of 
the Good Laboratory Practice, GLP), the international 
recommendations of the European Convention for the 
Protection of Vertebrate Animals used for Experimental 
and Other Scientific Purposes (The European Convention, 
1986). The protocol of the experimental study was 
approved by the Ethics Committee of Mechnikov Institute 
of Microbiology and Immunology of National Academy of 
Medical Sciences (protocol № 3-2018 of 14.12.2018). 
Animals were divided into 18 groups of 20 
animals per group. The first two control groups 1A and 1B 
were injected intraperitoneally with suspensions of live 
bacteria at a dose of 0.5 ml (9 log CFU) / mL of P. 
aeruginosa and E. coli, respectively. The remaining 16th 
groups of animals were administered the appropriate 
amount of vaccine (inactivated bacteria) preliminarily, 2 
weeks prior infection with bacteria.   
Inactivated RD-BL vaccines were administered to 
animals of groups 2AB - 5 AB (see Table 1), and animals 
of groups 6AB - 9AB were given vaccines inactivated with 
formalin (0.1% formalin in 9 log CFU was kept for 2 weeks 
in the thermostat and sterility was determined - bacterial 
growth was not observed). 
 
Materials 
Bacteria Isolation and Culture. XMR-strain Pseudomonas 
aeruginosa XMR IMI 047 and isolate XMR-strain of 
Escherichia coli XMR IMI 218 were selected for study. All 
bacterial strains isolated from patients with post-surgical 
complications were provided by the Department of Surgery 
of Kharkov National Medical University, Kharkov State 
Hospital N 17. The bacterial strains stored in the glycerol 
tube, then were inoculated in a blood culture dish and 
resuscitated two times to a logarithmic growth phase. Then 
the bacterial colonies were scraped with an inoculation 
loop and placed into the bacterial diluents. After sufficient 
mixing, 0.5 McFarland (MCF) turbidity standard bacterial 
suspensions were prepared using a turbid-meter 
(approximate bacteria concentration of 1∼2 x 109 colony 
forming units/mL, CFU/mL), which was used for the 
subsequent experiments. 
Blue Light Source and Photosensitizer. The blue 
light (BL) irradiation was performed with the LED point 
source (Luxeor-LC, Dealdent Co., Ltd., Kharkiv, Ukraine) 
with a wavelength of 450 nm. Calibration of the light 
energy was carried out before each experiment to ensure 
that the output power density was in range of 900 
mW/cm2∼1200 mW/cm2. The light power density was 
measured by optical power meter (Optical Power Meter 
ST805C PPM FTTX PON, Shandong Senter Electronic 
Co., Ltd., Shandong, China). The diameter of light spot 
was about 7 mm. In this experiment, the PS was riboflavin  
(Sigma-Aldrich Technology Co., Ltd., USA) and 
synthesized derivative (IV) or (RD) as shown in [15], that 
were dissolved into 0,02% wt solution with sterile 
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Methods 
Qualitative Observation of the Inhibition Effect on 
Bacteria 
In Vitro. Stock solution 0,2% wt of riboflavin, and RD 
(Riboflavin dynamic derivative – RD), was diluted to 0.1% 
wt with sterile PBS. In the experiment, four different 
samples were prepared which BL-RD treated sample 
(Group 1), control treated with BL alone (Group 2), control 
treated with RD alone (Group 3), and control untreated 
(Group 3). 200 𝜇L bacterial suspension (0.5MCF) was 
aseptically transferred into the 9 cm blood agar plates with 
properly labeled test positions of control samples and BL-
RD treated sample. 10 𝜇L diluent RD solution (0.1% wt) 
was added in each labeled test position of BL-RD treated 
sample and RD alone treated control sample. Before 
exposure to BL, the samples to be irradiated were 
incubated in dark for 20 min. 450 nm BL was used to 
irradiate BL-RD treated sample and BL alone treated 
sample. The samples were irradiated by different power of 
BL light (912,5 mW/cm2, 1024,2   mW/ cm2, 1111,8 mW/ 
cm2, 1209,9 mW/ cm2.) for 3 min. The entire 
experimentation was carried out in the dark box to avoid 
the influence of the ambient light. After irradiation, the 
experimental samples were incubated at 37∘C for 48 hours. 
And then the growth situation of bacteria in different 
groups was observed and recorded. The detailed 
experiment setup is shown in Figure 1. 
 
Bacteria Inactivation Experiments In Vitro (1) Inhibition 
Effect of Different BL Energy. 0.5 MCF bacteria 
suspensions of E. coli and P. aeruginosa diluted into 1:10 
with PBS were taken as BL alone group samples. 100 𝜇L 
bacteria suspensions (0.5 MCF) and 400 𝜇L RD solution 
(2.5% wt) were taken into 500 𝜇L PBS as BL-RD group 
samples. The initial population densities of experimental 
samples were both maintained at about 109 CFU/ml and the 
concentration of RD solution was about 0.02%wt. 150 𝜇L 
aliquots of the sample solutions were subjected to 96-well 
culture plates (BioRad, New York, USA). The inside 
diameter of the well is about 5 mm. The distance of light 
source to surface of solution was 5 mm. And the light spot 
diameter was about 7 mm at this distance, which was larger 
than the well and enabled satisfying irradiation of 
suspension surface with BL. The illumination was 
conducted in dark box to prevent photosensitization of 
riboflavin from background visible light. The energy 
density was 912,501 mW/ cm2, 1024,209 mW/ cm2, 
1209,920 mW/ cm2, respectively, and the irradiation time 
was 3 min. For the control group samples, the suspensions 
in 96-well plates were kept in the dark at room temperature 
for 3 min. 
Cell Concentration Determination and Survival 
Fraction Calculation. After the experimental treatments, 
aliquots (100 𝜇L) were withdrawn from each well and 
serially diluted 10-fold with PBS. Ten microliters from 
each dilution mixture was streaked onto blood agar plates 
(BioRad, New York, USA) in triplicate. After incubation 
for 48 hours at 370C, bacterial colonies were counted. 
The survival fraction was calculated according to 
the equation 𝑁/No., where No. is the number of CFU / mL 
of bacteria without being treated and 𝑁 is the number of 
CFU / mL of bacteria treated with BL and RD. All results 
were presented as means ± standard deviation (SD) of at 
least three independent experiments and each was 
measured in triplicate.  
Statistical Analysis. Experimental data were 
confirmed to be of normal distribution by the K-S test. 
Descriptive statistics were used to summarize the data in 
multiplex analyses. The results were shown as the means ± 
SD. The statistical significance between groups was 
determined using two-way analysis of variance (ANOVA). 
𝑃 < 0.05 were considered to be statistically significant. 
 
Results & discussion 
In the first experiment, it was necessary to select 
the optimal radiation power, which would effectively 
inactivate the bacterial suspension for 3 minutes of 
exposure time. With a longer exposure time, the solution 
begins to heat up significantly. Table 1 shows the 
dependence of the percentage of surviving bacteria based 






Table 1. Survival fraction of E. coli and P. aeruginosa with different BL energy in the BL-RD group (irradiation 
time: 3 min) 
 
Power density (mW/cm2) Survival fraction of E. coli (%)  Survival fraction of P. aeruginosa 
(%) (B) 
0 100 100 
912,5 12,3±2,9 22,5±2,4 
1024,2    1,3±0,4 3,5±0,5 
1111,8 0 0 
1209,9 0 0 
 
As can be seen from table 1. the most effective 
was irradiation of the solution at a flow rate of 1024.2-
1111.8 mW / cm2. For further experiments, we chose a 
power of 1024.2 mW / cm2, during which some single 
colonies still survive and this power represents the lowest 
limit of efficiency. 
The second experiment was to demonstrate the 
ability of a new dynamic derivative with its minimum 
content in solution to inactivate the experimental bacterial 
suspensions under the influence of visible light. Fig. 1 
shows an experiment with pure riboflavin as a control 
substance. 
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Fig 1 The number of survival bacterial colonies under different conditions of experiment (R: riboflavin (I); BL: blue 
light) to E. coli and (light power density: 1024,2 mW/ cm2) 
 
As can be seen from Figure 1, control samples 
without BL irradiation and not containing riboflavin (R-, 
BL-) remained viable in the range of 8.7-8.6 Log (CFU) / 
mL. The samples containing riboflavin that were not 
irradiated with BL (R +, BL-) did not statistically differ 
from the control group. Samples not containing riboflavin 
but irradiated with BL (R-, BL +) showed a statistically 
insignificant upward trend in (8.77–8.9) Log (CFU) / mL. 
A statistically significant decrease in the number of live 
bacteria was observed only for the sample containing 
riboflavin and irradiated with BL and amounted to (6.2-
5.8) Log (CFU) / mL, respectively. In Figure 2, we present 
a similar experiment with a dynamic succinylated 
riboflavin derivative with incompletely substituted 
hydroxyl groups with respect to the carbohydrate 
component RD. Due to the presence of residues of carboxyl 
groups in different positions and combinations, the 
molecule penetrates better into the cell, and the lability of 
the ester bond leads to the formation of pure riboflavin and 
free succinic and maleic acids inside the cell. This allows 
you to significantly enhance the effectiveness of 
photodynamic inactivation at the same concentration of the 
photodynamic agent RD. 



























Fig.2. The number of survival bacterial colonies under different conditions of experiment (RD: riboflavin derivative; 
BL: blue light) to E. coli and (light power density: 1024,2 mW/ cm2) 
 
As can be seen from Figure 2, control samples 
without BL exposure and not containing RD remained 
viable in the range of 8.7-8.6 Log (CFU) / mL. Samples 
containing RD but not irradiated with BL (RD +, BL-) did 
not statistically differ from the control group.  A sample 
not containing RD but irradiated with BL (RD-, BL +) 
again showed a statistically insignificant tendency to 
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increase (8.6-8.9) Log (CFU) / mL, but only for E. coli. A 
statistically significant decrease in the number of live 
bacteria almost to complete inactivation was observed only 
for a sample containing RD and irradiated BL and in the 
range of (0.32-0.12) Log (CFU) / mL, respectively. 
0.02% RD was capable of inactivating 6 orders 
magnitude more of bacteria (6 log CFU), than R at the same 
concentration. Then a suspension of P. aeruginosa and E. 
coli 4.0 Log (CFU) / mL was prepared, RD was added to a 
final concentration of 0.02%, and BL solutions were 
irradiated for 5 minutes at a power of 1024.2 mW / cm2. 
When the solution was irradiated for 5 minutes, the growth 
of bacteria was not determined (not shown in the graph). 
Inactivated suspensions were further used as particulate 
vaccines to study their effectiveness versus similar 
vaccines obtained by formalin treatment. Table 2 presents 
the results of a study of the protective properties of these 
vaccines. 
 
Table 2. Protection properties of photo inactivated and E. coli in mice model as pseudomonas and esherichiosis 
peritonitis (IP injection 1 mL 4 log (CFU)/mL microorganisms suspension per mouse)  
 
N Group/vaccine dose, mL, 
4 log (CFU)/mL  
Mice survival under vaccination by RD-BL inactivated bacteria, 
n=20 
P. aeruginosa (А) E. coli (B) 
1 Control* 4 6 
2 0,05  4 7 
3 0,1 91 151 
4 0,5 201,2,3 201,2,3 
5 1,0 201,2,3 201,2,3 
  Mice survival under vaccination by formalin inactivated bacteria 
(FIB), n=20 
6 0,05  3 4 
7 0,1 3 5 
8 0,5 71,3 91,3 
9 1,0 121,3 141,3 
*- vaccination by 0,9% sol. NaCl 
1 – statistically differences from Control, (P<0,05) 
2- statistically differences from corresponding groups (4 and 8, 5 and 9), (P<0,05) 
3- statistically differences from corresponding groups (4,5 and 8, 9), (P<0,05) 
 
As can be seen from table 2, in the control group, instead 
of vaccines, 1.0 ml of Normal saline was given 
intravenously.  The 2 weeks later after infection was 
administered to control group, only 4 mice survived from 
20 animals in group A, and only 6 animals in group B. 
Vaccination of animals with vaccine in doses of 0.05 ml 4 
log (CFU) / mL for the experimental study of RD-BL and 
for the variant with formalin inactivated bacteria (FIB) did 
not statistically differ from the control group. For formalin-
inactivated bacteria vaccines, a dose of 0.1 ml of 4 log 
(CFU) / mL also did not lead to a statistically significant 
increase in mouse life expectancy. For the experimental 
group, inactivated RD-BL, the dose of 0.1 ml statistically 
significantly differed both from the control and from the 
same dose of FIB vaccines. An increase in vaccine doses 
up to 0.5 ml gave more significant statistical differences 
not only from the control group, but also between the RD-
BL and FIB groups. If a dose of 0.5 ml of 4 log (CFU) / 
mL was used in the RD-BL group, all animals in group A 
and group B survived. For a dose of 1 ml of 4 log (CFU) / 
mL in the RD-BL experimental group, all animals also 
survived. Whereas for formalin inactivated bacteria (FIB) 
groups, a 100% protective effect was not achieved, 
although the number of surviving animals was 4 times 
greater than in the control. 
 
Conclusions 
1. The dynamic derivative of riboflavin RD based on 
combinatorial succinylated - maleated riboflavin has 
photodynamic microbicidal activity in the visible 
irradiation spectrum with respect to P.aeruginosa and 
E.coli 
2. 0.02% RD can photoinactivate 6 time more bacteria 
P.aeruginosa and E. coli than riboflavin. 
3. The minimum effective BL power (450 nm) for the 
photodynamic inactivation of RD of both P.aeruginosa 
and E. coli is 1024.2 mW / cm2, irradiation of which for 3 
minutes leads to the survival of some single colonies. 
4. A 5-minute irradiation of bacterial suspensions of P. 
aeruginosa and E. coli BL in the presence of RD at a power 
of 1024.2 mW / cm2 leads to a complete loss of bacterial 
viability. 
5. In groups of mice pre-vaccinated intraperitoneally with 
corpuscular vaccines BL-RD based on suspensions of 
P.aeruginosa and E. coli at doses of 0.5-1.0 ml 4 log (CFU) 
/ mL, 100% survival of all animals was observed, whereas 
in control group with the same type of vaccines but 
formalin-treated vaccines, a 100% protective effect was not 
achieved. 
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Improving vaccine efficacy based on non-covalent 
photoinactivation of microorganisms - sources vaccine 
antigens (MSVA) 
Martynov A., Farber B., Osolodchenko T., Klein I. 
One of the most promising methods for non-covalent 
inactivation of vaccine-producing microorganisms is the 
use of photoinactivation using riboflavin derivatives. The 
study used a dynamic combinatorial derivative of 
riboflavin - succinyl-maleinyl riboflavin.      
Corpuscular vaccines are divided into the following 
groups: from 2AB to 5AB - bacteria were inactivated by 
riboflavin derivative and blue light, and groups from 6AB 
to 9AB were inactivated by formalin (0.1% formalin in 9 
log CFU was kept for 2 weeks in an thermostat and then 
sterility was determined - bacterial growth was not 
observed). A dynamic derivative of riboflavin at a final 
concentration of 0.02% can photo inactivate 6 time more 
bacteria P. Aeruginosa and E. coli than riboflavin. The 
minimum effective blue light emitter power (450 nm) for 
the photodynamic inactivation of both P. aeruginosa and 
E. coli is 1024.2 mW / cm2. In groups of mice pre-
vaccinated intraperitoneally with corpuscular photo 
inactivated vaccines based on suspensions of and E. coli 
at doses of 0.5-1.0 ml 4 log (CFU) / mL, 100% survival of 
all animals was observed, whereas in control group with 
the same type of vaccines but formalin-treated vaccines, it 
failed to achieve a 100% protective effect. 
Keywords: vaccines; non-covalent inactivation; 
photodynamic; riboflavin derivatives; visible light; E. 
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